All In Biotech

Free tool

FAERS Monitor: Rocuronium Bromide

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 219108 or its brand name (Rocuronium Bromide, Rocuronium Bromide). Reports on generic versions are filed under their own applications.

Reports

5,786

Serious

5,018

87% of reports

Hospitalization

1,794

Death reported

441

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • anaphylactic shock693
  • drug ineffective690
  • anaphylactic reaction618
  • hypotension519
  • cardiac arrest355
  • tachycardia214
  • bronchospasm212
  • bradycardia197
  • rash182
  • drug interaction168
  • urticaria159
  • off label use157
  • oxygen saturation decreased144
  • respiratory failure129
  • blood pressure decreased125

Reports by year received

View as table
YearReports
200418
200551
200636
200755
2008107
2009177
2010196
2011267
2012270
2013116
2014150
2015138
2016263
2017209
2018272
2019375
2020314
2021303
2022415
2023487
2024459
2025542
2026566

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,048,373 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
anaphylactic shockSignal693100.493.566,358
bronchospasmSignal21254.848.010,985
anaphylactic reactionSignal61841.138.123,935
cardiac arrestSignal35515.714.24,867
bradycardiaSignal19713.611.82,275
hypotensionSignal5199.48.73,929
oxygen saturation decreasedSignal1449.37.91,064
tachycardiaSignal2148.87.71,469
blood pressure decreasedSignal1256.85.8619
respiratory failureSignal1296.45.4588
drug interactionSignal1683.93.3354
urticariaSignal1593.53.0276
drug ineffective6901.91.8315
rash1821.51.332
off label use1570.70.630

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.